Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bram Verstockt

Showing results (111-120 of 167) with videos related to

Pageof 17
Sort By:
Journal of Crohn'S & Colitis|June 23, 2021
ECCO Topical Review: Refractory Inflammatory Bowel DiseaseTim Raine, Bram Verstockt, Uri Kopylov, et al.
Alimentary Pharmacology & Therapeutics|April 29, 2022
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitisBram Verstockt, Valery Volk, Charlot Jaeckel, et al.
Journal of Crohn'S & Colitis|June 20, 2020
Neutrophilic HGF-MET Signalling Exacerbates Intestinal InflammationMichelle Stakenborg, Bram Verstockt, Elisa Meroni, et al.
Inflammatory Bowel Diseases|December 10, 2024
MIP4IBD: An Easy and Rapid Genotyping-by-Sequencing Assay for the Inflammatory Bowel Diseases Risk LociSare Verstockt, Laurens Hannes, Deborah Sarah Jans, et al.
Journal of Crohn'S & Colitis|October 6, 2023
Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE StudiesBram Verstockt, Valerie Pivorunas, Naim Al Mahi, et al.
Journal of Crohn'S & Colitis|April 17, 2025
Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitisBram Verstockt, Dahham Alsoud, Joep van Oostrom, et al.
Journal of Crohn'S & Colitis|January 19, 2019
Gene and Mirna Regulatory Networks During Different Stages of Crohn's DiseaseSare Verstockt, Gert De Hertogh, Jan Van der Goten, et al.
Journal of Crohn'S & Colitis|December 1, 2022
Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case seriesHussein Mahajna, Bram Verstockt, Daniel Bergemalm, et al.
Journal of Crohn'S & Colitis|March 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitisEmmanuel Niyigena, Yannick Hoffert, Waqqas Afif, et al.
Journal of Crohn'S & Colitis|November 12, 2023
The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b StudyBram Verstockt, Severine Vermeire, Laurent Peyrin-Biroulet, et al.
Pageof 17

Showing results (111-120 of 167) with videos related to

Sort By:
Pageof 17
Journal of Crohn'S & Colitis|June 23, 2021
ECCO Topical Review: Refractory Inflammatory Bowel DiseaseTim Raine, Bram Verstockt, Uri Kopylov, et al.
Alimentary Pharmacology & Therapeutics|April 29, 2022
Longitudinal monitoring of STAT3 phosphorylation and histologic outcome of tofacitinib therapy in patients with ulcerative colitisBram Verstockt, Valery Volk, Charlot Jaeckel, et al.
Journal of Crohn'S & Colitis|June 20, 2020
Neutrophilic HGF-MET Signalling Exacerbates Intestinal InflammationMichelle Stakenborg, Bram Verstockt, Elisa Meroni, et al.
Inflammatory Bowel Diseases|December 10, 2024
MIP4IBD: An Easy and Rapid Genotyping-by-Sequencing Assay for the Inflammatory Bowel Diseases Risk LociSare Verstockt, Laurens Hannes, Deborah Sarah Jans, et al.
Journal of Crohn'S & Colitis|October 6, 2023
Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn's Disease in the SERENE StudiesBram Verstockt, Valerie Pivorunas, Naim Al Mahi, et al.
Journal of Crohn'S & Colitis|April 17, 2025
Drug tissue concentration and STAT3 modulation as determinants of tofacitinib response in ulcerative colitisBram Verstockt, Dahham Alsoud, Joep van Oostrom, et al.
Journal of Crohn'S & Colitis|January 19, 2019
Gene and Mirna Regulatory Networks During Different Stages of Crohn's DiseaseSare Verstockt, Gert De Hertogh, Jan Van der Goten, et al.
Journal of Crohn'S & Colitis|December 1, 2022
Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case seriesHussein Mahajna, Bram Verstockt, Daniel Bergemalm, et al.
Journal of Crohn'S & Colitis|March 24, 2026
Personalized infliximab rescue therapy to maximize colectomy-free survival in patients with acute severe ulcerative colitisEmmanuel Niyigena, Yannick Hoffert, Waqqas Afif, et al.
Journal of Crohn'S & Colitis|November 12, 2023
The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b StudyBram Verstockt, Severine Vermeire, Laurent Peyrin-Biroulet, et al.
Pageof 17